Mario Filion
Gründer bei Alethia Biotherapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Mario Filion
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mario Filion
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| 9342-8530 QUÉBEC INC. | Medical Specialties | Director/Board Member | |
| BELLUS HEALTH | Pharmaceuticals: Major | Corporate Officer/Principal | |
| THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Fasken Martineau DuMoulin LLP
 Fasken Martineau DuMoulin LLP Miscellaneous Commercial ServicesCommercial Services Fasken Martineau DuMoulin LLP operates as law firm. It provides legal services to construction, financial, insurance, life sciences, corporate, and commercial industry. It offers Labour employment and human rights, litigation and dispute resolution, and privacy and cybersecurity risk management. The company was founded in 1863 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| McGill University | College/University | Masters Business Admin Doctorate Degree | |
BDC Venture Capital
 BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada. | Investment Managers | Private Equity Investor | |
| University of London | College/University | Undergraduate Degree | |
| University of Ottawa | College/University | Doctorate Degree | |
| University of Toronto | College/University | Graduate Degree | |
| University of Western Ontario | College/University | Undergraduate Degree | |
| University of Montréal | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Chief Tech/Sci/R&D Officer | |
LymphoSign, Inc.
 LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada. | Biotechnology | Director/Board Member | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
GeneChem Management, Inc.
 GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | Investment Managers | Private Equity Investor | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genome Canada
 Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Chairman | |
Miles Laboratories, Inc.
 Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Miles Laboratories, Inc. manufactures pharmaceutical products. The company is based in Rexdale, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AgeChem Financial, Inc.
 AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada. | Financial Conglomerates | Director/Board Member | |
Abbott Laboratories Ltd.
 Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937. | Pharmaceuticals: Major | Sales & Marketing | |
BioAxone Therapeutic, Inc.
 BioAxone Therapeutic, Inc. Medical/Nursing ServicesHealth Services BioAxone Therapeutic, Inc. provides an experimental therapy for the treatment of neurological disorders. The company was founded in April 2000 by Pierre Caouette and Lisa Mckerracher and is headquartered in Montreal, Canada. | Medical/Nursing Services | Chairman | |
BCF LLP
 BCF LLP Miscellaneous Commercial ServicesCommercial Services Part of BCF Capital SENC, BCF LLP is a Canadian company that provides legal services. The company is based in Québec, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| SignalGene, Inc. | Corporate Officer/Principal | ||
| Glaxo Canada, Inc. | Corporate Officer/Principal | ||
| ACERUS PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
LUMA Capital LLC
 LUMA Capital LLC Investment ManagersFinance LUMA Capital LLC provides investment advice. The private company is based in Naples, FL. The company was founded by Luc Mainville. | Investment Managers | Founder | |
AmorChem Financial, Inc.
 AmorChem Financial, Inc. Financial ConglomeratesFinance AmorChem Financial, Inc. provides financial investment services. The company is headquartered in Westmount, Canada. | Financial Conglomerates | Chairman | |
Insitut de Recherche en Immunologie et en Cancérologie
 Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Chief Executive Officer | |
| CHITOGENX INC. | Biotechnology | Director of Finance/CFO | |
| VALEO PHARMA INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Neopharm Labs, Inc.
 Neopharm Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Neopharm Labs, Inc. provides analytical laboratory testing services in collaboration with pharmaceutical, medical devices, natural health and cosmetic clients. It offers natural health products, medical marijuana to veterinary and cosmetics markets. The company was founded in 1990 and is headquartered in Blainville, Canada. | Miscellaneous Commercial Services | Chief Executive Officer | |
AAA Medic Montreal, Inc.
 AAA Medic Montreal, Inc. Agricultural Commodities/MillingProcess Industries AAA Medic Montreal, Inc. engages in production, cultivation and distribution of medicinal cannabis. The company was founded by Renaud Adams and is headquartered in Montreal, Canada. | Agricultural Commodities/Milling | Director/Board Member | |
Zucara Therapeutics, Inc.
 Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chairman | |
Corbin Therapeutics, Inc.
 Corbin Therapeutics, Inc. Internet Software/ServicesTechnology Services Corbin Therapeutics, Inc. operates as a biotechnology platform. | Internet Software/Services | Director/Board Member | |
| LUMA Life, Inc. | President | ||
Giiant Pharma, Inc.
 Giiant Pharma, Inc. BiotechnologyHealth Technology Giiant Pharma, Inc. is a Canadian preclinical-stage biotech company that specializes in designing gut-restricted small molecule drug therapeutics with various biological targets in gastroenterology. The company is based in Montréal, Canada and was founded by Elizabeth Elizabeth Kwong. The company's proprietary precision delivery technology platform allows for the creation of tissue-specific drugs with improved tolerability and enhanced therapeutic effects. Giiant's first lead program, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug. Maxime Ranger has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
| STARPAX BIOPHARMA INC. | Director/Board Member | ||
| LSL PHARMA GROUP INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Université du Québec à Montréal | College/University | Masters Business Admin |
Statistik
International
| Kanada | 46 |
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 23 |
| Commercial Services | 8 |
| Consumer Services | 8 |
| Finance | 6 |
| Miscellaneous | 2 |
Operativ
| Director/Board Member | 26 |
| Corporate Officer/Principal | 25 |
| Director of Finance/CFO | 7 |
| Doctorate Degree | 5 |
| Chief Executive Officer | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Mario Filion
- Unternehmensverbindungen
